Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
- PMID: 33604257
- PMCID: PMC7868692
- DOI: 10.14218/JCTH.2020.00082
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
Abstract
Globally, the rise in prevalence of obesity and metabolic syndrome as a whole has been linked to increased access to processed foods, such as refined sugars and saturated fats. Consequently, nonalcoholic fatty liver disease (NAFLD) is on the rise in both developed and developing nations. However, much is still unknown on the NAFLD phenotype with regards to the effect of ethnic diversity. Despite similarities in dietary habits, it appears that certain ethnicities are more protected against NAFLD than others. However, manifestations of the same genetic polymorphisms in different groups of people increase those individuals' predisposition to NAFLD. Diets from different regions have been associated with a lower prevalence of NAFLD and have even been linked to regression of hepatic steatosis. Socioeconomic variations amongst different regions of the world also contribute to NAFLD prevalence and associated complications. Thus, a thorough understanding of ethnic variability in NAFLD is essential to tailoring treatment recommendations to patients of different backgrounds.
Keywords: Body mass index; Diversity; Ethnicity; Lean; Nonalcoholic fatty liver; Nonalcoholic steatohepatitis.
© 2021 Authors.
Conflict of interest statement
The authors have no conflict of interests related to this publication.
Figures
Similar articles
-
Nonobese Fatty Liver Disease.Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28. Clin Gastroenterol Hepatol. 2017. PMID: 27581063 Review.
-
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review.Biomedicines. 2022 Dec 30;11(1):106. doi: 10.3390/biomedicines11010106. Biomedicines. 2022. PMID: 36672614 Free PMC article. Review.
-
Dietary approach in the treatment of nonalcoholic fatty liver disease.World J Hepatol. 2015 Oct 28;7(24):2522-34. doi: 10.4254/wjh.v7.i24.2522. World J Hepatol. 2015. PMID: 26523205 Free PMC article. Review.
-
Nonalcoholic fatty liver disease in Asia: emerging perspectives.J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16. J Gastroenterol. 2017. PMID: 27637587 Review.
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263. World J Gastroenterol. 2017. PMID: 29307986 Free PMC article. Review.
Cited by
-
Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.Front Nutr. 2024 Jul 2;11:1426780. doi: 10.3389/fnut.2024.1426780. eCollection 2024. Front Nutr. 2024. PMID: 39021599 Free PMC article. Review.
-
Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.PLoS One. 2024 Feb 23;19(2):e0298662. doi: 10.1371/journal.pone.0298662. eCollection 2024. PLoS One. 2024. PMID: 38394065 Free PMC article.
-
Greater Muscular Strength Is Associated with a Lower Risk of Pulmonary Dysfunction in Individuals with Non-Alcoholic Fatty Liver Disease.J Clin Med. 2022 Jul 17;11(14):4151. doi: 10.3390/jcm11144151. J Clin Med. 2022. PMID: 35887915 Free PMC article.
-
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.World J Gastroenterol. 2024 Jun 28;30(24):3106-3119. doi: 10.3748/wjg.v30.i24.3106. World J Gastroenterol. 2024. PMID: 38983957 Free PMC article.
-
Association of nonalcoholic fatty liver disease with the different types of dietary carbohydrates: a cross-sectional study.J Diabetes Metab Disord. 2023 Jun 14;22(2):1139-1143. doi: 10.1007/s40200-023-01223-3. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975105 Free PMC article.
References
-
- Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s gastrointestinal and liver disease: Pathophysiology/diagnosis/management. Philadelphia, PA: Saunders/Elsevier; 2016.
Publication types
LinkOut - more resources
Full Text Sources